Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 3 records, 1 pages
Search For: Somatostatin Analogue Drug
Global Somatostatin Analogue Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Somatostatin Analogue Drug market size was valued at USD 6132.5 million in 2023 and is forecast to a readjusted size of USD 9534.6 million by 2030 with a CAGR of 6.5% during review period.
USD3480.00
Add To Cart
Global Somatostatin Analogue Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029
26 Feb 2023
Pharma & Healthcare
Somatostatin analogues are drugs that stop your body from making too many hormones. Some neuroendocrine tumours (NETs) make large amounts of hormones that cause a group of symptoms called carcinoid syndrome. Somatostatin analogues are a possible treatment for people with carcinoid syndrome.
USD3480.00
Add To Cart
Global Somatostatin Analogue Drug Supply, Demand and Key Producers, 2023-2029
01 Feb 2023
Pharma & Healthcare
The global Somatostatin Analogue Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Somatostatin Analogue Drug
Total: 3 records, 1 pages
According to our (Global Info Research) latest study, the global Somatostatin Analogue Drug market size was valued at USD 6132.5 million in 2023 and is forecast to a readjusted size of USD 9534.6 million by 2030 with a CAGR of 6.5% during review period.
USD3480.00
Add To Cart
Somatostatin analogues are drugs that stop your body from making too many hormones. Some neuroendocrine tumours (NETs) make large amounts of hormones that cause a group of symptoms called carcinoid syndrome. Somatostatin analogues are a possible treatment for people with carcinoid syndrome.
USD3480.00
Add To Cart
The global Somatostatin Analogue Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>